Transplantation and Cellular Therapy Impact Factor 2026: 1.19, Quartile

Publishing your own paper?

Get it ready for the right journal with a PhD expert in your field.

Manuscript Auditing

A PhD reviewer in your exact area sends a structured, section-by-section critical review.

AI plagiarism and similarity report included
Secure, confidential upload

Audit duration: within 1 weekCheck price →

If the journal needs LaTeX

LaTeX Template Conversion

We convert your manuscript into the LaTeX template your target journal requires.

Check price →

If your paper was out of scope

Journal Selection & Submission

Up to 5 journals matched to your indexing (SCIE / Scopus) and quartile
Submission handled, with weekly updates

With LaTeX conversion: within 2 Working DaysCheck price →

What is ScholarsColab?

ScholarsColab is a freelancing platform built for researchers, with a pool of research doctorates registered to mentor them. Hire one in your research area and cut your research timeline from 2 years to 2 months.

Know more →

At a glanceTransplantation and Cellular Therapy is listed in SCIE, Scopus, JCR 2024. Published by Elsevier BV, it has 22,344 published works, cited 270,436 times (h-index 169). Its impact factor* of 1.19 ranks it 20 of 33 in Transplantation. Papers by ScholarsColab mentors and the researchers we track appear here as soon as they publish in it. Data updated 22 October 2026.

Official website Guide for authors and submission Check my manuscript first

Impact factor*1.19Rank 20 of 33 in Transplantation IndexingSCIEScopusJCR 2024Confirm on the official lists before you submit Article fee (APC)US$3,650See if your author team can get a waiver

RetractionsNoneNone on record under this name

LaTeX template available

Elsevier BV provides LaTeX templates for many of its journals. Check this journal’s author guidelines, and we can convert your manuscript into its template.

LaTeX Template Conversion →

01Impact factor

Impact factor of Transplantation and Cellular Therapy (2026)

Impact factor (2-year)1.19calculated by ScholarsColab

Rank in category#20of 33 by citedness

APC (listed)US$3,650article charge

h-index169

Papers published22,344cited 270,436 times

The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers Transplantation and Cellular Therapy published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, calculated by ScholarsColab. The journal is listed in JCR 2024, so it also has an official Journal Impact Factor published by Clarivate, which can differ because it counts citations from Web of Science journals only.

Rank in its subject categories

Transplantationrank 20 of 33 journals
Hematologyrank 68 of 104 journals
Immunologyrank 159 of 189 journals

Ranks here compare journals of the same Web of Science category in our data by 2-year citedness; they are not the official JCR rank.

Quartile of Transplantation and Cellular Therapy

A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Transplantation and Cellular Therapy is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.

Citations and papers per year

Citations per year

Papers per year

Article processing charge listed at about US$3,650.

Please check the final impact factor. The impact factor and APC on this page are calculated by ScholarsColab (updated 17 October 2026) and can differ from the official values. Confirm the current impact factor and charges on the journal’s website or in Clarivate’s Journal Citation Reports before you submit.

Is your paper a fit for Transplantation and Cellular Therapy?

Most desk rejections come from a scope mismatch. Compare your title and abstract with what this journal really publishes. Free, no sign-up, about 2 minutes.

Check my paper for this journal Or find journals that fit my paper

Need a faster review? The fastest journals in Immunology accept papers in a median of 14 days.

HLA 14 days
Immunological Reviews 33 days
Clinical and Experimental Vaccine Research 40 days

All fastest journals in this field

APC waivers and discounts for Transplantation and Cellular Therapy APC about US$3,650

Elsevier: automatic 100% waiver for Research4Life Group A and 50% for Group B in fully open access journals, but only when every author is in an eligible country. Authors in 82 countries get a full waiver.

Check the APC for my country

02Indexing

Indexing of Transplantation and Cellular Therapy

List	Status
Science Citation Index Expanded (SCIE)	✓ Listed
Social Sciences Citation Index (SSCI)	Not listed
Arts & Humanities Citation Index (AHCI)	Not listed
Emerging Sources Citation Index (ESCI)	Not listed
Scopus	✓ Listed
Journal Citation Reports 2024	✓ Listed

ISSN: 1083-8791
eISSN: 1523-6536
Publisher: Elsevier BV all its journals →
Subjects: Hematology, Immunology, Transplantation

From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor on this page is calculated by ScholarsColab (see how the impact factor works).

Verify the indexing yourself

Each link opens the official record for this journal, searched by its ISSN where we have one.

03How to submit

How to submit to Transplantation and Cellular Therapy

Read the guide for authors. It sets the article types, word limit, reference style and file format that Transplantation and Cellular Therapy accepts. Open the official guide for authors and submit from the same page.
Use the journal's template. Elsevier BV offers Word and LaTeX templates for many of its journals. If your manuscript is in Word and the journal wants LaTeX, our LaTeX Template Conversion moves it into the template.
Check the fit. Read the aims and scope and a few recent issues; papers outside the scope are the most common reason for a desk rejection. The Journal Finder shows journals that published the closest work.
Check the fee. Transplantation and Cellular Therapy is not a fully open access journal, so authors usually pay nothing unless they choose open access for their article or the journal charges page or colour fees. The guide for authors states the current charges.
Check your manuscript before you submit. The free Submission Readiness Check asks the seven questions our reviewers ask in every audit and takes about 2 minutes.

04Reviewer comments

Reviewer comments and rejection reasons for Transplantation and Cellular Therapy

No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.

Across the reviewer comments researchers have shared with us, the points raised most often are figures, tables and equations (21%), literature and references (12%) and novelty and contribution (10%). Before you submit to Transplantation and Cellular Therapy, a Manuscript Audit by a PhD reviewer in your area checks your paper against exactly these points.

Audit my paper before I submit →

Worried about the English? Manuscript editing by editors in your subject: see the price →

Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 seconds

05Same subject

Transplantation journals with a similar impact factor*

The journals next to Transplantation and Cellular Therapy when the 31 journals of Transplantation in our data are ranked by impact factor*:

Rank	Journal	Impact factor*	Indexing	Open access
16	The International Journal of Artificial Organs	1.46	SCIE	Subscription
17	Nephrology Dialysis Transplantation	1.41	SCIE	Subscription
18	Pediatric Transplantation	1.40	SCIE	Subscription
19	Annals of Transplantation	1.39	SCIE	Subscription
21	ASAIO Journal	1.05	SCIE	Subscription
22	Transplant Research and Risk Management	1.00	ESCI	Some open access
23	American Journal of Transplantation	0.98	SCIE	Subscription
24	Transplantation	0.95	SCIE	Subscription

*Impact factor calculated by ScholarsColab (2-year citedness), not the official Clarivate value.

FreeNo AI

Is Transplantation and Cellular Therapy right for your paper? Find the right journal

Paste your title, keywords or abstract. See the journals that published the closest papers, with indexing, impact factor, review time and APC.

Try:

Publishing open access? Your author team may not have to pay the APC. Free APC waiver check for your country→

How it works

No AI or language model is used. Your words are matched against the titles of 157,115 real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; the impact factor is calculated by ScholarsColab, not the official Clarivate value, and no quartile is shown until the official JCR or SJR quartile can be; review time is the median days from submission to acceptance (not every publisher publishes these dates). Always check a journal’s scope and current indexing before submitting.

Want a PhD expert to shortlist and handle the submission? Journal Selection & Submission matches your manuscript to up to 5 suitable journals by indexing and quartile. Check price →

06Questions

Frequently asked questions

What is the impact factor of Transplantation and Cellular Therapy?

Based on ScholarsColab citation data (October 2026), the 2-year impact factor of Transplantation and Cellular Therapy is 1.19: papers it published in the two previous years were cited 1.19 times on average in a year. The journal is listed in JCR 2024, so Clarivate also publishes an official Journal Impact Factor, which can differ.

What is the h-index of Transplantation and Cellular Therapy?

The h-index of Transplantation and Cellular Therapy is 169 (October 2026): 169 of its papers have each been cited at least 169 times. Its i10-index is 4,778.

What is the APC of Transplantation and Cellular Therapy?

The listed article processing charge (APC) is about US$3,650 for Transplantation and Cellular Therapy (data from October 2026). APCs change and can differ by article type, country or discounts, so confirm the current charge on the journal’s website before submitting.

What is the quartile of Transplantation and Cellular Therapy?

Is Transplantation and Cellular Therapy indexed in Scopus?

Yes. Transplantation and Cellular Therapy appears in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.

Is Transplantation and Cellular Therapy an SCIE journal?

Yes. Transplantation and Cellular Therapy is listed in the Science Citation Index Expanded (SCIE), according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.

Is Transplantation and Cellular Therapy in Journal Citation Reports (JCR)?

Yes. Transplantation and Cellular Therapy is listed in JCR 2024, so it has a Journal Impact Factor. For the current impact factor and quartile, check Journal Citation Reports.

Does Transplantation and Cellular Therapy offer an APC waiver?

Transplantation and Cellular Therapy follows the policy of Elsevier: automatic 100% waiver for Research4Life Group A and 50% for Group B in fully open access journals, but only when every author is in an eligible country. Rules verified 27 October 2026; confirm on the publisher's page.